Literature DB >> 27693712

Design of efficient computational workflows for in silico drug repurposing.

Quentin Vanhaelen1, Polina Mamoshina2, Alexander M Aliper2, Artem Artemov2, Ksenia Lezhnina2, Ivan Ozerov2, Ivan Labat3, Alex Zhavoronkov2.   

Abstract

Here, we provide a comprehensive overview of the current status of in silico repurposing methods by establishing links between current technological trends, data availability and characteristics of the algorithms used in these methods. Using the case of the computational repurposing of fasudil as an alternative autophagy enhancer, we suggest a generic modular organization of a repurposing workflow. We also review 3D structure-based, similarity-based, inference-based and machine learning (ML)-based methods. We summarize the advantages and disadvantages of these methods to emphasize three current technical challenges. We finish by discussing current directions of research, including possibilities offered by new methods, such as deep learning.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27693712     DOI: 10.1016/j.drudis.2016.09.019

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  35 in total

1.  Validation strategies for target prediction methods.

Authors:  Neann Mathai; Ya Chen; Johannes Kirchmair
Journal:  Brief Bioinform       Date:  2020-05-21       Impact factor: 11.622

Review 2.  Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling.

Authors:  Linlin Zhao; Heather L Ciallella; Lauren M Aleksunes; Hao Zhu
Journal:  Drug Discov Today       Date:  2020-07-11       Impact factor: 7.851

3.  Framework and resource for more than 11,000 gene-transcript-protein-reaction associations in human metabolism.

Authors:  Jae Yong Ryu; Hyun Uk Kim; Sang Yup Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-24       Impact factor: 11.205

4.  DR2DI: a powerful computational tool for predicting novel drug-disease associations.

Authors:  Lu Lu; Hua Yu
Journal:  J Comput Aided Mol Des       Date:  2018-04-23       Impact factor: 3.686

5.  Text-mining in cancer research may help identify effective treatments.

Authors:  Yi-Wen Hsiao; Tzu-Pin Lu
Journal:  Transl Lung Cancer Res       Date:  2019-12

Review 6.  A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.

Authors:  Sushmitha S Purushotham; Neeharika M N Reddy; Michelle Ninochka D'Souza; Nilpawan Roy Choudhury; Anusa Ganguly; Niharika Gopalakrishna; Ravi Muddashetty; James P Clement
Journal:  Exp Brain Res       Date:  2022-09-05       Impact factor: 2.064

7.  The NAD+-mitophagy axis in healthy longevity and in artificial intelligence-based clinical applications.

Authors:  Yahyah Aman; Johannes Frank; Sofie Hindkjær Lautrup; Adrian Matysek; Zhangming Niu; Guang Yang; Liu Shi; Linda H Bergersen; Jon Storm-Mathisen; Lene J Rasmussen; Vilhelm A Bohr; Hilde Nilsen; Evandro F Fang
Journal:  Mech Ageing Dev       Date:  2019-12-05       Impact factor: 5.432

Review 8.  Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review.

Authors:  Neetu Tripathi; Manoj Kumar Goshisht; Sanat Kumar Sahu; Charu Arora
Journal:  Mol Divers       Date:  2021-06-10       Impact factor: 2.943

9.  Topological network measures for drug repositioning.

Authors:  Apurva Badkas; Sébastien De Landtsheer; Thomas Sauter
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

10.  The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology.

Authors:  Artur Kadurin; Alexander Aliper; Andrey Kazennov; Polina Mamoshina; Quentin Vanhaelen; Kuzma Khrabrov; Alex Zhavoronkov
Journal:  Oncotarget       Date:  2017-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.